Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD
Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of tolvaptan in
patients with autosomal dominant polycystic kidney disease (ADPKD) in the real world clinical
setting in Japan.